| Ytd | 36.21% | |
| 1y | 60.20% |
| Open | 21.29 | Prev Close | 20.99 | Low | 20.98 | High | 21.68 | Mkt Cap | 7.59B |
| Vol | 2.80M | Avg Vol | 3.82M | EPS | 0.27 | P/E | 78.85 | Forward P/E | 16.63 |
| Beta | 0.94 | Short Ratio | 7.43 | Inst. Own | 108.47% | Dividend | 0.36 | Div Yield | 1.72 |
| Ex Div Date | 09-11 | Earning | 10-26 | 50-d Avg | 19.63 | 200-d Avg | 18.80 | 1yr Est | 22.24 |
Nov Inc. (NOV) reported earnings 30 days ago. What's next for the stock?
Algert Global LLC trimmed its position in shares of NOV Inc. (NYSE: NOV) by 34.4% in the second quar
HOUSTON, Aug. 19, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE: NOV) announced today that its Board of Di
NOV Inc. has outperformed the energy sector recently, driven by oil price leverage and higher financ
NOV, Oil States International and Natural Gas Services have been highlighted in this Industry Outloo
Edgestream Partners L.P. reduced its stake in shares of NOV Inc. (NYSE: NOV) by 18.0% in the first q
Softer equipment demand and conservative capital spending by upstream players make the outlook for t
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and lowers the price
Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the pri
NOV's margin gains and record Energy Equipment profitability offset uneven revenues as backlog trend
NOV beats Q2 earnings and revenue estimates despite lower sales, as Energy Equipment strength, share
NOV NYSE: NOV reported second-quarter 2026 revenue of $2.13 billion and net income of $112 million,
Although the revenue and EPS for Nov Inc. (NOV) give a sense of how its business performed in the qu
NOV Inc. (NOV) Q2 2026 Earnings Call Transcript
Nov Inc. (NOV) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Esti
Revenues of $2.13 billion, up 4% sequentially and down 2% year-over-year Net income of $112 million,
NOV faces a key Q2 test as delayed shipments, strong order trends and cost cuts collide with ongoing
Nov Inc. (NOV) possesses the right combination of the two key ingredients for a likely earnings beat
NOV's technology gains, rising earnings estimates, strong backlog and shareholder returns strengthen
Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and lowers the pri
NOV provides a conservative balance sheet with a current ratio of roughly 2.4x and low debt levels.
-- Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phas
Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and raises the price targe
HOUSTON, June 16, 2026 (GLOBE NEWSWIRE) -- NOV Inc. (NYSE: NOV) will hold a conference call to discu
NOV Inc. (NYSE:NOV) announced today that its Board of Directors declared a regular quarterly cash di
Barclays analyst David Anderson downgrades NOV (NYSE:NOV) from Equal-Weight to Underweight and ra
RBC Capital analyst Keith Mackey maintains NOV (NYSE:NOV) with a Sector Perform and raises the pr
Evercore ISI Group analyst James West maintains NOV (NYSE:NOV) with a In-Line and raises the pric
Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the pri
Morgan Stanley analyst Daniel Kutz maintains NOV (NYSE:NOV) with a Equal-Weight and raises the pr
NOV Inc. (NYSE:NOV) announced today that operational disruptions resulting from the war in the Middl
RBC Capital analyst Keith Bachman downgrades NOV (NYSE:NOV) from Outperform to Sector Perform and
Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the pri
NOV to roughly double the capacity of its manufacturing facility in Brazil over the next three years
Goldman Sachs analyst Neil Mehta maintains NOV (NYSE:NOV) with a Sell and raises the price target
BMO Capital analyst Phillip Jungwirth maintains NOV (NYSE:NOV) with a Market Perform and raises t
Barclays analyst David Anderson upgrades NOV (NYSE:NOV) from Underweight to Equal-Weight and rais
Susquehanna analyst Charles Minervino maintains NOV (NYSE:NOV) with a Positive and raises the pri
Piper Sandler analyst Luke Lemoine maintains NOV (NYSE:NOV) with a Neutral and raises the price t
Barclays analyst David Anderson maintains NOV (NYSE:NOV) with a Underweight and raises the price
Citigroup analyst Scott Gruber maintains NOV (NYSE:NOV) with a Neutral and raises the price targe
NOV becomes investor in Natura Resources ("Natura") and appoints representative to Natura
NOV Inc. announced today that Clay Williams, Chairman and Chief Executive Officer will retire, and J
Armada, a leader in artificial intelligence at the edge, today announced a strategic collaboration w